Oral masitinib doubles the life in patients with amyotrophic lateral sclerosis.
Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.
Novartis and its alpelisib will help with very rare diseases with malformations and excessive tissue growth.
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.
Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.
Avacopan is better than prednisone in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.